Skip to main content
Premium Trial:

Request an Annual Quote

Gary Kruppa, Alnoor Shivji, Victor Joseph, Amjad Huda, Robert Pinco

Premium

Bruker Daltonics has hired Gary Kruppa as vice president for Western US Operations, which is based in Fremont, Calif. His position begins in February. Kruppa will be responsible for managing Bruker’s West Coast life-science mass-spectrometry applications laboratory, as well as all sales, service, and support operations in the Western United States.

Kruppa comes to Bruker from Sandia National Laboratories, where he was a principal member of the technical staff. In 1990, he was employed at Bruker Instruments, an affiliate of Bruker Daltonics, as an applications scientist.


Alnoor Shivji, Victor Joseph, and Amjad Huda have founded WaferGen, a Fremont, Calif., high-throughput screening and cell-based assay company. Shivji, the chairman of WaferGen, has founded three telecommunications companies that were sold to Ciena, Cisco, and Redback Networks, the company said. Joseph, an engineer, previously held positions at Cisco and Hewlett-Packard. Additional information on Huda was not available.


Robert Pinco has joined the advisory council at CyGene Laboratories, a Coral Springs, Fla., company that designs genetic-profiling and diagnostic-testing methods, the company said last week. Pinco currently co-chairs the BioMedical/FDA practice and the biotechnology group at the law firm Buchanan Ingersoll, in Washington, DC, CyGene said.

 

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.